Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells

Raloxifene hydrochloride (RAL), one of second generation of selective estrogen receptor modulators (SERMs), is usually used in preventing osteoporosis and breast cancer. The present study evaluated whether Raloxifene might sensitize multidrug resistant (MDR) breast cancers to chemotherapies, especia...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Main Authors: Xu, Liang, Lei, Jingyu, Jiang, Donghai, Zhou, Lin, Wang, Shu, Fan, Weimin
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2015
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847829/
https://ncbi.nlm.nih.gov/pubmed/26529585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1095409
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares